NCT03191474

Brief Summary

CCTG 602 is a multisite demonstration project to evaluate the effectiveness of facilitated linkage to PrEP using a community-based transgender PrEP outreach worker (T-POWr) versus standard of care (SOC).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
202

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2017

Typical duration for not_applicable

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 15, 2017

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 19, 2017

Completed
1 month until next milestone

Study Start

First participant enrolled

July 28, 2017

Completed
2.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2020

Completed
Last Updated

September 13, 2021

Status Verified

September 1, 2021

Enrollment Period

2.7 years

First QC Date

June 15, 2017

Last Update Submit

September 9, 2021

Conditions

Keywords

PrEPPre-exposure ProphylaxisTruvadaClient-centered case managementTransgenderGender non-conforming

Outcome Measures

Primary Outcomes (1)

  • Facilitated Linkage

    To evaluate the effectiveness of a T-POWr intervention to effectively link transgender / gender non-conforming persons to a PrEP evaluation visit.

    Baseline up to Week 28

Study Arms (2)

Standard of Care Arm

NO INTERVENTION

Participants will receive standard of care HIV risk assessment, PrEP education, and an appointment for a PrEP evaluation visit at an affiliated clinic.

T-POWr Intervention Arm

EXPERIMENTAL

Participants will receive the same HIV risk assessment, PrEP education, and appointment for a PrEP evaluation visit as the Control Arm. Participants in the Intervention Arm will also receive a thorough client-centered case management evaluation that will assess needs including access to health insurance, general health care, assessment of current hormone administration, housing, mental health care, domestic violence care, substance use treatment, and other services.

Behavioral: T-POWr Intervention

Interventions

All participants will be asked to complete a secure confidential online survey focusing on needs assessment. Participants in the T-POWr Intervention Arm will receive a client-centered case management consultation based on how the participant responds to the online survey. The T-POWr will refer participants to assistance services based on the needs assessment, including accessing general health care, health insurance, hormone replacement therapy, housing, mental health care, domestic violence care, substance use treatment, etc. Each resource is extensively vetted to assure a trans-friendly experience and will be tailored to each geographic area across the project enrollment sites. The study facilitates referrals for services but will not provide extensive and ongoing case management.

T-POWr Intervention Arm

Eligibility Criteria

Age18 Years+
Sexall(Gender-based eligibility)
Gender Eligibility DetailsTransgender or Gender Non-conforming, defined as identifying with a gender different from sex assigned at birth.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 18 years or older
  • Self-identifies as a transgender or gender non-conforming person
  • Self-identifies as HIV-negative or unknown status
  • Ability to provide informed consent
  • English or Spanish speaking

You may not qualify if:

  • Severe active substance abuse or mental illness that the investigator feels will interfere with the ability to provide informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Los Angeles Lesbian, Gay, Bisexual, and Transgender Center

Los Angeles, California, 90027, United States

Location

UC San Diego AntiViral Research Center (AVRC)

San Diego, California, 92103, United States

Location

Study Officials

  • Sheldon Morris, MD MPH

    CCTG, UCSD AVRC

    STUDY CHAIR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor

Study Record Dates

First Submitted

June 15, 2017

First Posted

June 19, 2017

Study Start

July 28, 2017

Primary Completion

March 31, 2020

Study Completion

March 31, 2020

Last Updated

September 13, 2021

Record last verified: 2021-09

Data Sharing

IPD Sharing
Will not share

Locations